Echopoint Medical secures £500k for cardiovascular sensing technology

Cardiovascular devices designed by London-based Echopoint Medical utilize optical sensors to provide imaging and physiological data during minimally invasive interventional cardiology procedures. The business, a spin-out from University College London, has secured an estimated £500k in its latest funding round.

Founded in 2018, the startup develops technology intended to reduce clinical complications and treatment costs while improving patient outcomes. Its technical specialties encompass laser physics, nanofabrication, and cardiac electrophysiology, alongside the use of optical ultrasound and data analytics.

The investment brings the total funding raised by the firm this year to £2.4m. This follows a capital intake of £236.1k recorded throughout 2025.

Financial filings for the year ended 31 December 2024 showed a headcount of six employees. More recent data from the company's social profiles suggests the team has since expanded to 17 people, including a mix of engineers, clinicians, and management staff. Formal documentation for this round was filed in July (following an allotment in June 2026).